TD Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-15,300
| Closed | -$658K | – | 1380 |
|
|
2018
Q4 | $658K | Sell |
15,300
-7,200
| -32% | -$310K | ﹤0.01% | 1162 |
|
|
2018
Q3 | $1.11M | Sell |
22,500
-4,700
| -17% | -$231K | ﹤0.01% | 1134 |
|
|
2018
Q2 | $872K | Sell |
27,200
-1,900
| -7% | -$60.9K | ﹤0.01% | 1163 |
|
|
2018
Q1 | $906K | Buy |
29,100
+1,800
| +7% | +$56K | ﹤0.01% | 1084 |
|
|
2017
Q4 | $1.25M | Buy |
27,300
+1,500
| +6% | +$68.5K | ﹤0.01% | 998 |
|
|
2017
Q3 | $969K | Sell |
25,800
-4,763
| -16% | -$179K | ﹤0.01% | 1040 |
|
|
2017
Q2 | $1.46M | Sell |
30,563
-5,700
| -16% | -$272K | ﹤0.01% | 952 |
|
|
2017
Q1 | $1.65M | Sell |
36,263
-5,800
| -14% | -$265K | ﹤0.01% | 929 |
|
|
2016
Q4 | $1.36M | Sell |
42,063
-20,137
| -32% | -$651K | ﹤0.01% | 948 |
|
|
2016
Q3 | $2.13M | Sell |
62,200
-14,000
| -18% | -$479K | ﹤0.01% | 867 |
|
|
2016
Q2 | $2.57M | Buy |
76,200
+4,200
| +6% | +$142K | ﹤0.01% | 814 |
|
|
2016
Q1 | $3.82M | Sell |
72,000
-2,700
| -4% | -$143K | 0.01% | 732 |
|
|
2015
Q4 | $5.74M | Buy |
74,700
+1,300
| +2% | +$99.8K | 0.01% | 612 |
|
|
2015
Q3 | $3.02M | Buy |
73,400
+2,100
| +3% | +$86.3K | 0.01% | 750 |
|
|
2015
Q2 | $5.04M | Sell |
71,300
-9,100
| -11% | -$644K | 0.01% | 674 |
|
|
2015
Q1 | $7.14M | Buy |
80,400
+7,500
| +10% | +$666K | 0.01% | 575 |
|
|
2014
Q4 | $6.46M | Sell |
72,900
-12,700
| -15% | -$1.13M | 0.01% | 600 |
|
|
2014
Q3 | $8.3M | Buy |
85,600
+6,400
| +8% | +$620K | 0.01% | 513 |
|
|
2014
Q2 | $7.28M | Sell |
79,200
-2,100
| -3% | -$193K | 0.01% | 548 |
|
|
2014
Q1 | $5.69M | Buy |
81,300
+5,000
| +7% | +$350K | 0.01% | 612 |
|
|
2013
Q4 | $4.39M | Sell |
76,300
-1,600
| -2% | -$92K | 0.01% | 665 |
|
|
2013
Q3 | $3.75M | Sell |
77,900
-3,500
| -4% | -$168K | 0.01% | 680 |
|
|
2013
Q2 | $2.36M | Buy |
+81,400
| New | +$2.36M | 0.01% | 738 |
|